Comparative Safety of High-Dose Versus Standard-Dose Influenza Vaccination in Patients With End-Stage Renal Disease

BACKGROUND: High-dose influenza vaccine (HDV) is an alternative vaccination strategy in patients with end-stage renal disease (ESRD), though the safety of HDV has not been evaluated in this population. The objective of this study was to estimate the relative occurrence of adverse vaccine reactions i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccine
Autors principals: Layton, J. Bradley, McGrath, Leah J., Sahrmann, John M., Ma, Yinjiao, Dharnidharka, Vikas R., O’Neil, Caroline, Weber, David J., Butler, Anne M.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7332402/
https://ncbi.nlm.nih.gov/pubmed/32565346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.06.020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars